Publications And Presentations

Health Analytics’ scientific team regularly contributes articles to trade and peer-reviewed publications. Our publications and presentations are just some examples of the many  pertinent resources our company provides for clients, peers, and the healthcare community.

PUBLICATIONS

Publication DatePublication TypeName of JournalConference PresentationAuthorsTitleLink
04/02/20222022Journal ArticleJournal of Affective Disorders ReportsRuetsch, C., Liberman J. N., Davis, T. H., Sajatovic, M., Velligan, D. I., Wiggins, E. K., & Forma, F. The Effect of Objectively Collected Medication Adherence Information on Bipolar I and Major Depressive Disorder Treatment Decisions: A Randomized Case Vignette Study of Psychiatric CliniciansLink to Publication
02/12/20222022Journal ArticlePsychiatric Research & Clinical PracticeLiberman, J. N., Davis, T., Velligan, D., Robinson, D., Carpenter, W., Jaeger, C., Waters, H., Ruetsch, C., & Forma, F.Mental Health Care Provider's Perspectives Toward Adopting a Novel Technology to Improve Medication AdherenceLink to Publication
02/28/20222022Journal ArticlePharmacoEconomics OpenAllen, K.B., Alexander, J.E., Liberman, J.N., & Gabriel, S.Implications of Payment for Acute Myocardial Infarctions as a 90-Day Bundled Single Episode of Care: A Cost of Illness AnalysisLink to Publication
12/16/20212021Journal ArticleNeuropsychiatric Disease & TreatmentRuetsch, C., Davis, T., Liberman, J.N., Velligan, D.I., Robinson, D., Jaeger, C., Carpenter, W., & Forma, F. Prescriber Attitudes, Experiences, and Proclivities Toward Digital Medicine and How They Influence Adoption of Digital Medicine PlatformsLink to Publication
08/01/20202020Journal ArticleJournal of Managed Care & Specialty PharmacyLiberman, J. N., Davis, T., Pesa, J., Chow, W., Verbanac, J., Heverly-Fitt, S., & Ruetsch, C.Predicting Incident Treatment-Resistant Depression: A Model Designed for Health Systems of CareLink to Publication
12/01/20192019Journal ArticleAmerican Journal of Managed CareWaters, H.C., Ruetsch, C., & Tkacz, J.A Claims-Based Algorithm to Reduce Relapse and Cost in SchizophreniaLink to Publication
02/01/20172017Journal ArticlePopulation Health ManagementBrady, B.L., Tkacz, J. P., Meyer, R., Bolge, S., & Ruetsch, C.Assessment of Rheumatoid Arthritis Quality Process Measures and Associated CostsLink to Publication
07/12/20192019Journal ArticleAmerican Journal of Managed CareNg-Mak, D., & Ruetsch, C.Association Between Meaningful Use of Electronic Health Records and Patient Health Outcomes in Schizophrenia: A Retrospective Database AnalysisLink to Publication
07/28/20182018Journal ArticleDrugs in R&DBray, V. J., Broadwell, A., Baraf, H. S. B., Black, S., Brady, B. L., Tkacz, J., Yarngo, L., & DeHoratius, R. J.The Effectiveness of Intravenous Golimumab Administered Directly After Infliximab in Rheumatoid Arthritis PatientsLink to Publication
11/22/20172018Journal ArticleClinical Schizophrenia & Related PsychosesVelligan, D., Carpenter, W., Waters, H. C., Gerlanc, N. M., Legacy, S. N., & Ruetsch, C.Relapse Risk Assessment for Schizophrenia Patients (RASP): A New Self-Report Screening ToolLink to Publication
05/07/20182018Journal ArticleClinicoEconomics & Outcomes ResearchRuetsch, C., Un, H., & Waters, H. C.Claims-based Proxies of Patient Instability among Commercially Insured Adults with SchizophreniaLink to Publication
06/27/20172017Journal ArticleAmerican Journal of Managed CareRuetsch, C., Tkacz, J., Nadipelli, V. R., Brady, B. L., Ronquest, N., Un, H., & Volpicelli, J.Heterogeneity of Nonadherent Buprenorphine Patients: Subgroup Characteristics and OutcomesLink to Publication
03/20/20172017Journal ArticleDiabetes, Metabolic Syndrome, and Obesity: Targets and TherapyGerlanc, N. M., Cai, J., Tkacz, J., Bolge, S. C., & Brady, B. L.The Association of Weight Loss with Patient Experience and Outcomes in a Population of Patients with Type 2 Diabetes Mellitus Prescribed CanagliflozinLink to Publication
06/27/20172017Journal ArticlePatient Preference & AdherenceShafrin, J., May, S. G., Shrestha, A., Ruetsch, C., Gerlanc, N., Forma, F., Hatch, A., Lakdawalla, D. N., & Lindenmayer, J.-P.Access to Credible Information on Schizophrenia Patients’ Medication Adherence by Prescribers Can Change their Treatment Strategies: Evidence from an Online Survey of ProvidersLink to Publication
05/01/20162016Journal ArticleValue in HealthBrady, B. L., Tkacz, J. P., Nadipelli, V., Volpicelli, J., Ronquest, N., Un, H., Roebuck, C., & Ruetsch, C.Relapse In Opioid Use Disorder: Implications For Health Care Utilization And CostsLink to Publication
11/01/20152015Journal ArticleJournal of Managed Care & Specialty PharmacyTkacz, J., Brady, B. L., Meyer, R., Lofland, J. H., Ruetsch, C., & Coelho-Prabhu, N.An Assessment of the AGA and CCFA Quality Indicators in a Sample of Patients Diagnosed with Inflammatory Bowel DiseaseLink to Publication
02/01/20152015Journal ArticleJournal of Managed Care & Specialty PharmacyTkacz, J. P., Ellis, L., Meyer, R., Bolge, S., Brady, B. L., & Ruetsch, C.Quality Process Measures for Rheumatoid Arthritis: Performance from Members Enrolled in a National Health PlanLink to Publication
12/01/20152015Journal ArticleAmerican Health & Drug BenefitsTkacz, J. P., Ingham, M. P., Brady, B. L., Meyer, R., & Ruetsch, C.Novel Adherence Measures for Infusible Therapeutic Agents Indicated for Rheumatoid ArthritisLink to Publication
05/01/20142014Journal ArticleClinical TherapeuticsTkacz, J. P., Ellis, L., Bolge, S., Meyer, R., Brady, B. L., & Ruetsch, C.Utilization and Adherence Patterns of Subcutaneously Administered Anti–Tumor Necrosis Factor Treatment Among Rheumatoid Arthritis PatientsLink to Publication
04/01/20142014Journal ArticleJournal of Substance Abuse TreatmentTkacz, J. P., Volpicelli, J., Un, H., & Ruetsch, C.Relationship Between Buprenorphine Adherence and Health Service Utilization and Costs Among Opioid Dependent PatientsLink to Publication
09/17/20142014Journal ArticleJAMARuetsch, C.Treating Prescription Opioid DependenceLink to Publication
04/01/20142014Journal ArticleAmerican Health & Drug BenefitsTkacz, J. P., Lofland, J. H., Vanderpoel, J., & Ruetsch, C.Infliximab Dosing Patterns in a Sample of Patients with Crohn's Disease: Results from a Medical Chart ReviewLink to Publication
02/21/20132013Journal ArticleJournal of Pain ResearchRuetsch, C., Tkacz, J. P., Kardel, P., Howe, A., Pai, H., & Levitan, B.Trajectories of Health Care Service Utilization and Differences in Patient Characteristics Among Adults with Specific Chronic Pain: Analysis of Health Plan Member ClaimsLink to Publication
11/19/20132013Journal ArticleAmerican Journal of Managed CareTkacz, J. P., Pesa, J., Vo, L., Kardel, P. G., Un, H., Volpicelli, J., & Ruetsch, C.Opioid Analgesic-Treated Chronic Pain Patients At Risk for Problematic UseLink to Publication
05/01/20122012Journal ArticleAddictive BehaviorsRuetsch, C., Tkacz, J. P., McPherson, T. L., & Cacciola, J.The Effect of Telephonic Patient Support on Treatment for Opioid Dependence: Outcomes at One Year Follow-UpLink to Publication
04/27/20122012Journal ArticleJournal of Addictive DiseasesTkacz, J. P., Severt, J., Kassed, C., & Ruetsch, C.Clinical Differences Between Opioid Abuse Classes Ameliorated After 1 Year of Buprenorphine-Medication Assisted TreatmentLink to Publication
05/01/20102010PresentationValue in HealthInternational Society for Pharmacoeconomic and Outcomes Research Annual Meeting 2010Ruetsch, C. & Tkacz, J.Opioid Relapse Rates Among a Sample of New Buprenorphine-Medication Assisted Treatment Patients: Relationship to Medication Compliance at One YearLink to Publication
09/28/20102011Journal ArticleInformation Technology Essentials for Behavioral Health CliniciansRuetsch, C., Tkacz, J. P., & Dewan, N. Improving Quality and Accountability Through Information SystemsLink to Publication
12/01/20102010Journal ArticleJournal of Addiction MedicineAlbright, J., Ciaverelli, R., Essex, A., Tkacz, J., & Ruetsch, C.Psychiatrist Characteristics That Influence Use of Buprenorphine Medication-Assisted TreatmentLink to Publication
12/01/20102010Journal ArticleJournal of Substance Abuse TreatmentRuetsch, C., Cacciola, J., & Tkacz, J. P.A National Study of a Telephone Support Service for Patients Receiving Office-Based Buprenorphine Medication-Assisted Treatment: Study feasibility and Sample DescriptionLink to Publication
06/17/20102010PresentationAmerican Journal on AddictionsAmerican Academy of Addiction Psychiatry Annual Meeting 2010Ruetsch, C. & Tkacz, J.Buprenorphine-Medication Assisted Treatment: A Retrospective Analysis of Health Plan DataLink to Publication
06/17/20102010PresentationAmerican Journal on AddictionsAmerican Academy of Addiction Psychiatry Annual Meeting 2010Ruetsch, C. & Tkacz, J.Differences in Opioid Dependence Severity by Health Insurance Ameliorated by Month Six of Buprenorphine TreatmentLink to Publication
06/17/20102010PresentationAmerican Journal on AddictionsAmerican Academy of Addiction Psychiatry Annual Meeting 2010Ruetsch, C. & Tkacz, J.Predictors of Buprenorphine-Medication Assisted Treatment Compliance Among Opioid-Dependence Patients: Results at Month SixLink to Publication
06/17/20102010PresentationAmerican Journal on AddictionsAmerican Academy of Addiction Psychiatry Annual Meeting 2010Ruetsch, C. & Tkacz, J.Compliance with Buprenorphine-Medication Assisted Treatment Decreases Drug use Among Opiate Addicts: A Randomization Controlled TrialLink to Publication
01/01/20102010Journal ArticleJournal of Managed Care & Specialty PharmacyJan, S., Ruetsch, C., Nicholls, L., & Bragaw, L.Opioid Dependence: Managing the High Cost of Treatment FailureLink to Publication
01/01/20102010Journal ArticleJournal of Managed Care & Specialty PharmacyNicholls, L., Bragaw, L., & Ruetsch, C.Opioid Dependence Treatment and GuidelinesLink to Publication
01/01/20102010Journal ArticleJournal of Managed Care & Specialty PharmacyRuetsch, C.Empirical View of Opioid DependenceLink to Publication
01/01/20102010Journal ArticleJournal of Managed Care & Specialty PharmacyRuetsch, C.Practice Strategies to Improve Compliance and Patient Self-ManagementLink to Publication
12/15/20052005Journal ArticleSchizophrenia ResearchPotkin, S. G., Gharabawi, G., Greenspan, A., Rupnow, M., Kosik-Gonzalez, C., Remington, G., Ruetsch, C., & Revicki, D.Psychometric Evaluation of the Readiness for Discharge QuestionnaireLink to Publication
05/16/20222022PresentationInternational Society for Pharmacoeconomics and Outcomes Research Annual Meeting 2022Boskovic, D.H., Liberman, J.N., Wiggins, E., & Parab, P.Early Experience with Aripiprazole Tablets with Sensor: Patient Costs from Real-World DataLink to Publication
03/29/20222022PresentationAcademy of Managed Care Pharmacy Annual Meeting 2022Davis, T, Parab, P, May, D, & Ruetsch, C.Characteristics, Comorbid Conditions, and Treatment Patterns Among Male Individuals Diagnosed with Rett Syndrome
10/29/20212021PresentationPsych Congress 2021Liberman, J.N., Pesa, J.A., Petrillo, M., & Ruetsch, C. Increase in COVID-19 Infections among Individuals with Schizophrenia in the United States and the Impact of Race/Ethnicity
10/29/20212021PresentationPsych Congress 2021Liberman, J.N., Rui, P., Ruetsch, C., Pesa, J., Lakey, S., Teeple, A. & Ahmedani, B. Factors Associated with High-Risk and High-Cost Events Following MDD Diagnosis
10/29/20212021PresentationPsych Congress 2021Davis, T., Parab, P., Ruetsch, C. & Boskovic, D.H.Demographics, Service Utilization, and Antipsychotic Therapy Adherence Among Patients Prior to a Prescription for Aripiprazole Tablets with SensorLink to Publication
05/01/20212021PresentationAmerican Psychiatric Association Annual Meeting 2021Forma, F., Liberman, J.N, Rui, P. & Ruetsch, C.Measuring Response to Adjunctive Therapy among MDD Patients on an Antidepressant
05/01/20212021PresentationAmerican Psychiatric Association Annual Meeting 2021Liberman, J.N., Pesa, J., Petrillo, M.P. & Ruetsch, C. Reductions in Behavioral Healthcare Service Use Among Patients with Schizophrenia Associated with the COVID-19 Pandemic
05/17/20212021PresentationInternational Society for Pharmacoeconomics and Outcomes Research (ISPOR) Annual Meeting 2021Forma, F., Liberman, J.N., Rui, P. & Ruetsch, C.Healthcare Costs Increase Substantially Following Adjunctive Therapy Among MDD Patients on Antidepressant Monotherapy
05/17/20212021PresentationInternational Society for Pharmacoeconomics and Outcomes Research (ISPOR) Annual Meeting 2021Pesa, J., Liberman, J.N., Petrillo, M.P. & Ruetsch, C. Early Impact of COVID-19 Pandemic on Antipsychotic Medication Use Among Patients with Schizophrenia
06/01/20212021PresentationAmerican Society of Clinical Psychopharmacology Annual Meeting 2021Forma, F., Liberman, J.N., Rui, P. & Ruetsch, C.Healthcare Costs Increase Substantially Following Adjunctive Therapy Among MDD Patients on Antidepressant Monotherapy
06/01/20212021PresentationAmerican Society of Clinical Psychopharmacology Annual Meeting 2021Forma, F., Liberman, J.N., Rui, P. & Ruetsch, C.Comorbidities and Service Utilization among Patients with MDD on ADT and Adjunctive Pharmacotherapy or Adjunctive Pharmacotherapy or Adjunctive Psychotherapy
04/12/20212021PresentationAcademy of Managed Care Pharmacy (AMCP) Annual Meeting 2021Forma, F., Liberman, J.N., Rui, P. & Ruetsch, C.Adherence to Adjunctive Pharmacotherapy Enhanced By Psychotherapy
05/29/20202020PresentationAmerican Society of Clinical Psychopharmacology Annual Meeting 2020Ruetsch, C., Velligan, D., Robinson, D., Jaeger, C., Carpenter, W., Davis, T., Liberman, J.N., Clerie, J., Waters, H. & Forma, F. Prescriber Attitudes, Experiences, and Proclivities Toward Digital Medicine and How They Influence Adoption of Digital Medicine Platforms
09/10/20202020PresentationPsych Congress 2020Ruetsch, C., Liberman, J.N., Rui, P., Batista, A.E. & Forma, F. Antidepressant and Psychotherapy Treatments of Patients with MDD and Elevated PHQ-9 Score
10/03/20192019PresentationPsych Congress Annual Meeting 2019Young, C., Waters, H., Ruetsch, C., & Forma, F. The Cost of Improving Treatment Choices: Cost and Benefit of a Digital Medicine System that Collect and Reports Objective Medication Adherence
10/29/20192019PresentationAMCP Nexus 2019Ruetsch, C., Velligan, D., Robinson, D., Jaeger, D., Carpenter, W., Davis, T., Liberman, J.N., Clerie, J., Waters, H. & Forma, F.Assessment of Specific Barriers and Drivers on Provider Adoption and Appropriate use of Digital Medication Adherence Platforms
10/03/20192019PresentationPsych Congress 2019Ruetsch, C., Velligan, D., Robinson, D., Jaeger, C., Carpenter, W., Davis, T., Liberman, J.N., Clerie, J., Waters, H. & Forma, F.A Comparison of Barriers and Drivers Between Prescribing and Non-Prescribing Psychiatric Care Providers Regarding Use of Digital Medication Adherence Platforms
05/18/20192019PresentationInternational Society for Pharmacoeconomics and Outcomes Research (ISPOR) Annual Meeting 2019Davis, T., Liberman, J., Allen, A., Young, C., Budlong, H., Heverly-Fitt, S., Nahas, Z., Verbanac, J., Chow, W., Pesa, J., & Ruetsch, C.Patient-reported Outcomes (PRO) Collected as Part of the Clinical Process: The Challenge of Administering, Scoring, and Storing PHQ Scores Beyond the Clinical Moment
10/29/20192019PresentationAMCP Nexus 2019Davis, T., Pesa, J., Budlong, H., McNamara, A., Snyder, M., Bibeau, W., Allen, A., Liberman, J., & Ruetsch, C.Adherence to Subcutaneous Biologic Therapy Among Patients With Inflammatory Bowel Disease and Rheumatoid Arthritis: Impact of Therapy Management
06/29/20182018PresentationAmerican Society of Clinical Psychopharmacology (ASCP) Annual Meeting 2018Ruetsch, C., Clerie, J., Sajatovic, M., Velligan, D., Davis, T., & Forma, F. The Impact of Adherence Information on Prescriber Prescription Decisions in Bipolar and Major Depressive Disorder
04/23/20182018PresentationAcademy of Managed Care Pharmacy (AMCP) Annual Meeting 2018Lee, E., Heverly-Fitt, S., Stark, J., Ruetsch, C., Davis, T., Weinblatt, M., Shadick, N. A., Frits, M., Iannaccone, C., & Yassine, M.Patient-Reported Clinical Outcomes Associated with Biologic Switching within Rheumatoid Arthritis
05/18/20192019PresentationInternational Society for Pharmacoeconomics and Outcomes Research (ISPOR) Annual Meeting 2019Young, C., Liberman, J., & Ruetsch, C. Comparison of Major Adverse Coronary Events and Costs of Care Among AMI Patients Receiving Stents, By Multivessel Disease Status
03/27/20172017PresentationAcademy of Managed Care Pharmacy (AMCP) Annual Meeting 2017Ng-Mak, D., Ruetsch, C., Brady, B. L., Tkacz, J., & Rajagopalan, K.Relationship Between EMR Utilization, Healthcare Quality, and Patient Outcomes: Analysis from a Nationally-Representative Sample of Schizophrenia Patients
10/21/20162016PresentationPsych Congress 2016Ruetsch, C., Tkacz, J., Psalmonds, L., Blaising, R., Gregory, R., Stevens, K., Guerra, O., Badgett, C., Wilbanks, J., & Waters, H.Developing a Claims-Based Case-Finding Algorithm to Identify Patients With Schizophrenia at Elevated Risk of Relapse
05/01/20162016International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Annual Meeting 2016Tkacz, J., Brady, B., Nadipelli, V., Volpicelli, J., Ronquest, N., Un, H., & Ruetsch, C.Opioid Use Disorder Population: Who is at Risk of Medication Assisted Treatment Non-Adherence?
05/01/20162016PresentationInternational Society for Pharmacoeconomics and Outcomes Research (ISPOR) Annual Meeting 2016Tkacz, J., Brady, B., Nadipelli, V., Volpicelli, J., Ronquest, N., Un, H., & Ruetsch, C.Opioid Use Disorder Population: Who is at Risk of Medication Assisted Treatment Non-Adherence?
05/01/20162016PresentationInternational Society for Pharmacoeconomics and Outcomes Research (ISPOR) Annual Meeting 2016Velligan, D., Ruetsch, C., Legacy, S., Waters, H., Gerlanc, N., & Carpenter, W.Psychometric Evaluation of a New Schizophrenia Patient Relapse Risk Screener
09/10/20152015PresentationPsych Congress 2015Velligan, D., Carpenter, W., Waters, H., Legacy, S., & Ruetsch, C.Development of a Self-Reported Schizophrenia Relapse Risk Factor Screener
09/05/20122012PresentationPain WeekKardel, P., Pesa, J., Tkacz, J. P., Un, H., Volpicelli, J., & Ruetsch, C.True Rate of Patients that Cross Over to Problematic Opioid Use within Opiate Analgesic Therapy for Chronic Non-Cancer
09/05/20122012PresentationPain WeekTkacz, J. P., Kardel, P., Pesa, J., Un, H., Volpicelli, J., & Ruetsch, C. Problematic Opioid Use and Opioid Addiction Amongst Aetna’s Opioid Analgesic Treated Chronic Pain Population: An Analysis of Healthcare Service Utilization and Costs
04/18/20122012PresentationAcademy of Managed Care Pharmacy (AMCP) Annual Meeting 2016Bolge, S. C., Tkacz, J. P., Kassed, C. A., Ruetsch, C., Ingham, M. P., & Wong, W.Dosing Patterns of Infliximab in Rheumatoid Arthritis Patients Enrolled in a Mid-Atlantic Commercial Health Plan
12/01/20112011PresentationCCFA 2011Lofland, J. H., Vanderpoel, J., Kassed, C. A., Tkacz, J. P., Nicholls, L., & Ruetsch, C.Stability of Infliximab Dosing Among Individuals with Crohn’s Disease: Results from a Mid-Atlantic Healthplan
12/01/20112011PresentationCCFA 2011Vanderpoel, J., Lofland, J. H., Bolge, S., Schenkel, B., Mody, S., Kassed, C., Ruetsch, C., Tkacz, J., Nichols, L., & Tanner, J.Infliximab Utilization Patterns within an Alternate Site of Care Setting among Patients with Inflammatory Bowel Disease
11/18/20112011PresentationAmerican College of Gastroenterology Annual Meeting 2011Schmeichel Mueller, C., Denny, L., Tkacz, J. P., & Ruetsch, C.Infliximab Infusion Patterns in Patients with Crohn’s Disease Naive to Biologic Therapy: An Analysis of a National Health Plan
11/05/20112011PresentationInternational Society for Pharmacoeconomics and Outcomes Research (ISPOR) Annual Meeting 2011Severt, J. H., Tkacz, J. P., & Ruetsch, C.Differences Between Opioid Dependent Patients in Italy and Germany: Receiving Substitution Therapy
11/05/20112011PresentationISPOR Europe 2011Severt, J., Tkacz, J. P., & Ruetsch, C.Physician Differences Between Italy and Germany: The Treatment of Opioid Dependence with Substitution Therapy
05/21/20112011PresentationInternational Society for Pharmacoeconomics and Outcomes Research (ISPOR) Annual Meeting 2011Schmeichel, C., Denny, L., Tkacz, J. P., & Ruetsch, C.Infliximab Infusion Patterns in Patients with Rheumatoid Arthritis Naive to Biologic Therapy: An Analysis of a National Health Plan
05/21/20112011PresentationInternational Society for Pharmacoeconomics and Outcomes Research (ISPOR) Annual Meeting 2011Tkacz, J. P., & Ruetsch, C.Differences in Baseline Problem Severity Between Prescription and Street Opioid Abusers Ameliorated After Participation in Disease Management Program: Results at One Year
05/21/20112011PresentationInternational Society for Pharmacoeconomics and Outcomes Research (ISPOR) Annual Meeting 2011Tkacz, J. P., & Ruetsch, C.New Disease Management Program for Opioid Dependent Patients Decreases Drug Use and Increases 12-Step Meeting Attendance: One-Year Results of a Randomized Clinical Trial
05/21/20112011PresentationInternational Society for Pharmacoeconomics and Outcomes Research (ISPOR) Annual Meeting 2011Tkacz, J. P., Un, H., Leader, D., & Ruetsch, C.The Effectiveness of Buprenorphine-Medication Assisted Treatment Among Aetna’s Opioid Dependent Members: An Analysis of Healthcare Costs and Service Utilization
05/21/20112011PresentationInternational Society for Pharmacoeconomics and Outcomes Research (ISPOR) Annual Meeting 2011Tkacz, J. P., Un, H., Leader, D., & Ruetsch, C.The Relationship Between Buprenorphine-Medication Assisted Treatment Adherence and Healthcare Costs and Service Utilization: An Analysis of Aetna’s Opioid Dependent Members
12/02/20102010PresentationAmerican Academy of Addiction Psychiatry (AAAP) 2010Ruetsch, C., Roebuck, C., & Tkacz, J. P.Buprenorphine Adherence Among Insured Patients with Opioid Dependence: Impact on Health Services Utilization and Cost
12/02/20102010PresentationAmerican Academy of Addiction Psychiatry (AAAP) 2010Severt, J., Tkacz, J. P., & Ruetsch, C.Buprenorphine Compliance is Associated with Improved Employment and Functioning Outcomes Among Opioid Dependent Patients
05/01/20102010PresentationInternational Society for Pharmacoeconomics and Outcomes Research (ISPOR) Annual Meeting 2010Ruetsch, C., & Tkacz, J. P.Opioid Relapse Rates Among a Sample of New Buprenorphine Medication Assisted Treatment Patients: Relationship with Medication Compliance at One YearLink to Publication
10/23/20102010PresentationAmerican Association for the Treatment of Opioid Dependence National Conference 2010Ruetsch, C., & Tkacz, J. P.Refusal of Ancillary Support Services Early in Opioid Dependence Treatment Predicts Six Month Buprenorphine-Medication Assisted Treatment Compliance
10/23/20102010PresentationAmerican Association for the Treatment of Opioid Dependence National Conference 2010Ruetsch, C., & Tkacz, J. P.The Effect of a Telephonic Patient Support Program on Treatment for Opioid Dependence: Outcomes at One Year
05/17/20102010PresentationInternational Society for Pharmacoeconomics and Outcomes Research (ISPOR) Annual Meeting 2010Ruetsch, C., & Tkacz, J. P.A Longitudinal Analysis of the Effect of Buprenorphine-Medication Assisted Treatment (B-MAT) and a Structured Patient Support Program on B-MAT Adherence in a National Sample of Opioid Dependent Patients
05/17/20102010PresentationInternational Society for Pharmacoeconomics and Outcomes Research (ISPOR) Annual Meeting 2010Ruetsch, C., & Tkacz, J. P.Opioid Relapse Rates Among A Sample of New Buprenorphine-Medication Assisted Treatment Patients: Relationship to Medication Compliance at One Year
05/17/20102010PresentationInternational Society for Pharmacoeconomics and Outcomes Research (ISPOR) Annual Meeting 2010Ruetsch, C., & Tkacz, J. P.Refusal of Ancillary Support Services Early in Treatment Predicts Six-Month Outcomes Among Buprenorphine-Medication Assisted Treatment Patients
05/17/20102010PresentationInternational Society for Pharmacoeconomics and Outcomes Research (ISPOR) Annual Meeting 2010Ruetsch, C., & Tkacz, J. P.The Effect of a Telephonic Patient Support Program on Treatment Outcomes Among a Sample of Opioid Dependence Patients: One Year Follow-Up
04/22/20102010PresentationNational Institute on Drug Abuse - Blending Conference 2010Ruetsch, C., & Tkacz, J. P.Recruiting Opioid Dependent Patients Seeking Treatment in Office-based Settings: Methodology and Comparison to Normative Sample: One Year Follow-Up
04/22/20102010PresentationNational Institute on Drug Abuse - Blending Conference 2010Ruetsch, C., & Tkacz, J. P.Telephonic Compliance Enhancement Program for Patients Receiving Buprenorphine-Medication Assisted Therapy: Results at One Year
12/03/20092009PresentationAmerican Academy of Addiction Psychiatry - 20th Annual Meeting & Symposium (2009)Ruetsch, C., & Tkacz, J. P.Buprenorphine-Medication Assisted Therapy: A Full Economic Analysis of Health Plan Data
12/03/20092009PresentationAmerican Academy of Addiction Psychiatry - 20th Annual Meeting & Symposium (2009)Ruetsch, C., & Tkacz, J. P.Differences in Opioid Dependence Severity by Health Insurance Ameliorated by Month Three of Buprenorphine Treatment
12/03/20092009PresentationAmerican Academy of Addiction Psychiatry - 20th Annual Meeting & Symposium (2009)Ruetsch, C., & Tkacz, J.P.Drug Use Severity Predicts Subsequent Buprenorphine-Replacement Treatment Compliance and Drug use Behavior Among Opioid-Dependence Patients
12/03/20092009PresentationAmerican Academy of Addiction Psychiatry - 20th Annual Meeting & Symposium (2009)Tkacz, J. P., & Ruetsch, C.Compliance with Buprenorphine-Medication Assisted Therapy Decreases Drug Use Among Opiate Addicts: A Randomization Controlled Trail
10/07/20092009PresentationAcademy of Managed Care Pharmacy’s (AMCP) Educational Conference (2009)Ruetsch, C., Schoenberger, C. A., & Tkacz, J. P.Cost-Effectiveness of Medication-Replacement Therapy with Buprenorphine among Opioid-Dependent Patients: Results From A Retrospective Analysis of Health Plan Membership Claims Data
10/07/20092009PresentationAcademy of Managed Care Pharmacy’s (AMCP) Educational Conference (2009)Ruetsch, C., Tkacz, J. P., & Schoenberger, C. A.Opioid Dependence Treatment Outcomes Improve With Addition of Structured Patient Support Program
09/10/20092009PresentationISPOR Latin America 2009Ruetsch, C., & Schoenberger, C. A.Factors That Predict Early Treatment Failure Among Patients In Outpatient Treatment For Opioid Dependence
09/10/20092009PresentationISPOR Latin America 2009Ruetsch, C., & Schoenberger, C. A.Methods For Achieving and Maintaining Adequate Study Subject Participation For A Multi-Site Time-Series Trail
05/16/20092009PresentationInternational Society for Pharmacoeconomics and Outcomes Research (ISPOR) Annual Meeting 2009Ruetsch, C., Schoenberger, C. A., & Tkacz, J. P.Factors That Influence Decisions among MBHO Network Physicians to Use Office-Based Treatment for Opioid Dependence or to Increase Numbers of Opioid-Dependent Patients They Treat: Results and Psychometric Evaluation of the OBOT Attitude and Intention Physician Survey
05/16/20092009PresentationInternational Society for Pharmacoeconomics and Outcomes Research (ISPOR) Annual Meeting 2009Ruetsch, C., Schoenberger, C. A., & Tkacz, J. P.Methods for Optimizing Subject Recruitment and Retention Through Private Practice Offices
05/01/20052005PresentationInternational Congress on Schizophrenia Research (2005)Buckley, P., Rupnow, M., Greenspan, A., Gharabawi, G., Bossie, C., Zhu, Y., Kosik-Gonzalez, C., Ruetsch, C., Revicki, D., & Anand, R.Readiness for Discharge Questionnaire: Relationship With Measures Of Symptom Improvement In Patients With Schizophrenia Or Schizoaffective Disorder And Psychometric Properties
06/02/20222022Journal ArticleBMC PsychiatryLiberman, J. N., Pesa, J., Petrillo, M. P., & Ruetsch, C.Factors Associated With Covid-19 Infection Among A National Population Of Individuals With Schizophrenia Or Schizoaffective Disorder In The United StatesLink to Publication
06/01/20212021Journal ArticleJournal of American Pharmacists AssociationPaliwal, Y., Jones, R. M., Moczygemba, L. R., Gendron, T. L., Nadpara, P. A., Parab, PN., & Slattum, P. W. Over-The-Counter Medication Use In Residents Of Senior Living Communities: A Survey StudyLink to Publication
11/20/20202020Journal ArticleAmerican Journal of MedicineOstfeld, R. J., Allen, K. E., Aspry, K., Brandt, E. J., Spitz, A., Liberman, J., Belardo, D., O'Keefe, J. H., Aggarwal, M., Miller, M., Batiste, C., Kopecky, S., White, B., Shah, N., Hawamdeh, H., Batts, T., Blankstein, R., Reddy, K., Ornish, D., & Freeman, A. MVasculogenic Erectile Dysfunction: The Impact of Diet and LifestyleLink to Publication
10/21/20212021Journal ArticleCNS SpectrumsRuetsch, C., Velligan, D., Robinson, D., Jaeger, C., Carpenter, W., Davis, T., Liberman JN., Clerie, J., Waters, J., & Forma, F. Psychiatric Prescriber Attitudes, Experiences, and Proclivities Toward Digital Medicine and How They Influence Adoption of Digital Medicine PlatformsLink to Publication
05/01/20202020Journal ArticleValue in HealthVaffis, S., Parab, PN., Amissah, J., Vohra, Y., Ravichandran, M., Gandhi, A. B., & Cohen, JPNS171 A Longitudinal Five-Year Review of the ISPOR Student Interest Survey: 2015-2016 to 2019-2020Link to Publication
07/01/20212021Journal ArticleThe Journal of Behavioral Health Services & ResearchForma, F., Clerie, J., Davis, T., Clovie, K., & Ruetsch, C.The Association between Patient Activation and Outcomes Among Severely Mentally Ill PatientsLink to Publication
02/21/20202020Journal ArticleCancer Causes & ControlSanto, L., Ward, B. W., Rui, P., & Ashman, JJ.Antineoplastic Drugs Prescription During Visits By Adult Cancer Patients With Comorbidities: Findings From The 2010–2016 National Ambulatory Medical Care SurveyLink to Publication
12/03/20202020Journal ArticlePharmacoeconomics and Pharmaceutical Economics CommonsParab, P.N.Development and Validation of Predictive Risk and Multiple Criteria Decision Analysis Models to Evaluate Cardiovascular Outcomes Among Cancer PatientsLink to Publication
05/01/20202020Journal ArticleValue in HealthParab, P.N., & Nadpara, P.AIncremental Healthcare Utilization Among Cancer Patients with Cardiovascular Diseases (CVD) as Compared to those Without CVD in the United States.Link to Publication
01/17/20202020PresentationNational Health Statistics ReportsSanto L., Rui P., & Ashman, J.J.Physician Office Visits at Which Benzodiazepines Were Prescribed: Findings From 2014-2016 National Ambulatory Medical Care SurveyLink to Publication
01/08/20202020Journal ArticleNational Health Statistics ReportsRui, P., Santo, L., & Ashman, J.J.Trends in Opioids Prescribed at Discharge From Emergency Departments Among Adults: United States, 2006-2017Link to Publication
05/01/20192019Journal ArticleValue in HealthDavis, T., Liberman, J. N., Allen, A., Young, C. H., Budlong, H., Heverly-Fitt, S., Nahas, Z., Verbanac, J., Chow, W., Pesa, J., & Ruetsch, C.Patient-Reported Outcomes (PRO) Collected as part of the Clinical Process: The Challenge of Administering, Scoring, Storing, and Interpreting PHQ-9 Scores Beyond the Clinical MomentLink to Publication
05/01/20192019Journal ArticleValue in HealthParab, PN., & Nadpara, PComparative Effectiveness of Novel Versus Rheumatoid Arthritis Therapies - A Systematic Literature ReviewLink to Publication
07/06/20222022Journal ArticleHealth Services Research and Managerial EpidemiologyLiberman, J. N., Bhattacharjee, S., Rui, P., Ruetsch, C., Rothman, B., Kulkarni, A., & Forma, F.Impact of the COVID-19 Pandemic on Healthcare Resource Utilization in Individuals with Major Depressive DisorderLink to Publication
11/01/20192019Journal ArticleAmerican Journal of Preventive MedicineSanto L, Rui P, Hales CM, Arem H, & Ogden CLTrends in Preventive Visits Among U.S. Youth Where Weight and Height Were Recorded: 2005–2016Link to Publication
01/01/20192019Journal ArticleNCHS Data BriefAshman J.J., Rui P., & Okeyode T.Characteristics of Office-based Physician Visits, 2016Link to Publication
11/15/20192019Journal ArticleNational Health Statistics ReportsRui P., Ashman JJ., & Akinseye A.Emergency Department Visits for Injuries Sustained During Sports and Recreational Activities by Patients Aged 5-24 Years, 2010-2016Link to Publication
01/01/20192019Journal ArticleCenter for Disease ControlRui P., Kang K.National Hospital Ambulatory Medical Care Survey: 2015 Emergency Department Summary TablesLink to Publication
06/01/20192019Journal ArticleThe American Journal of Managed CareRoebuck MC, & Liberman JNAssessing the Buden of Illness of Chronic Hepatitis C and Impact of Direct-Acting Antiviral Use on Healthcare Costs in MedicaidLink to Publication
04/05/20182018PresentationCirculation: Cardiovascular Quality and OutcomesLiberman, J., Jones, J. B., Yan, X. (S)., Husby, H., Takher, G., Bullano, M., & MacDonald, K.Early Impact of a Technology Solution to Transform Care for Cardiometabolic Conditions: Physician Experience and Patient-Centered OutcomesLink to Publication
05/01/20182018PresentationInternational Society for Pharmacoeconomics and Outcomes Research (ISPOR) Annual Meeting 2018Roebuck, M. C., & Liberman, J. N.Burden of Illness of Chronic Hepatitis C in MedicaidLink to Publication
02/09/20182018Journal ArticleMorbidity and Mortality Weekly Report (MMWR)Ashman, J.J., Rui, P., & DeFrances, C.J.QuickStats: Percentage* of All Emergency Department (ED) Visits† Made by Patients with Asthma,§ by Sex and Age Group — National Hospital Ambulatory Medical Care Survey, United States 2014–2015Link to Publication
12/21/20182018Journal ArticleMorbidity and Mortality Weekly Report (MMWR)Schappert, S.M., Rui, P., Ashman, J.J., & Defrances C.J.QuickStats: Percentage of Emergency Department (ED) Visits for Pain* at Which Opioids† Were Given or Prescribed, by Patient Age and Year — National Hospital Ambulatory Medical Care Survey, 2005–2016Link to Publication
12/14/20142014Journal ArticleNAMCS and NHAMCS Web TablesRui P., Hing, E., & Okeyode, T.National Ambulatory Medical Care Survey: 2014 State and National Summary TablesLink to Publication
06/06/20222022PresentationAcademy Health 2022 Annual Research MeetingShah, N., Velez, F., Anastassopoulos, K., Colman, S., Kauffman, L., Murphy, S., Ruetsch, C., Malone, D., & Maricich, Y.Comparison of Healthcare Resource Use over a 12-Month Follow-up Period in Medicaid-Covered Patients with Opioid Use Disorder with and without Use of a Prescription Digital TherapeuticLink to Publication
07/07/20222022Journal ArticleAdvances in TherapyVelez, F.F., Anastassopoulos, K.P., Colman, S., Shah, N., Kauffman, L., Murphy, S.M., Ruetsch, C., Maricich, Y.A.Reduced Healthcare Resource Utilization in Patients with Opioid Use Disorder in the 12 Months After Initiation of a Prescription Digital TherapeuticLink to Publication
03/29/20222022PresentationAcademy of Managed Care Pharmacy Annual Meeting 2022Boskovic, D.H., Liberman, J.N., Wiggins, E., & Parab, P.Early Experience with Aripiprazole Tablets with Sensor: Patient Characteristics, Utilization, and Cost from Real-World DataLink to Publication
10/29/20212021Journal ArticleClinicoEconomics and Outcomes ResearchVelez, F.F., Colman, S., Kauffman, L., Ruetsch, C., Anastassopoulos, K., Maricich, Y.A.Comparison of Healthcare Resource Utilization Between Patients Who Engaged or Did Not Engage With a Prescription Digital Therapeutic for Opioid Use DisorderLink to Publication
06/21/20212021Journal ArticleExpert Review of Pharmacoeconomics & Outcomes ResearchVelez, F.F., Ruetsch, C., & Maricich, Y. Evidence of Long-Term Real-World Reduction in Healthcare Resource Utilization Following Treatment of Opioid Use Disorder with reSET-O, a Novel Prescription Digital TherapeuticLink to Publication
10/14/20212021Journal ArticleEuropean Heart JournalGabriel, S., Liberman, J.N., Alexander, J.E., & Allen, K.B.Adherence to Guideline-Recommended Care Following Acute Myocardial Infarction: Impact on Clinical Outcomes at 90 Days and 1 YearLink to Publication
05/01/20202020Journal ArticleValue in HealthParab, P.N., & Nadpara, P. PCN223 Incremental Healthcare Utilization Among Cancer Patients with Cardiovascular Diseases (CVD) as Compared to Those Without CVD in the United StatesLink to Publication
12/03/20202020PresentationAmerican College of Clinical Pharmacy Annual Meeting (Virtual) 2020Liberman, J.N., Young, C., Pesa, J., Karkare, S., & Ruetsch, C.Implications of Healthcare Providers HEDIS-compliant Use of PHQ-9 to Monitor DepressionLink to Publication
02/01/20212021Journal ArticleExpert Review of Pharmacoeconomics & Outcomes ResearchVelez, F.F., Colman, S., Kauffman, L., Ruetsch, C., & Anastassopoulos, K.Real-world Reduction in Healthcare Resource Utilization Following Treatment of Opioid Use Disorder with reSET-O, a Novel Prescription Digital TherapeuticLink to Publication
07/12/20222022Journal ArticleAdvances in TherapyShah, N., Velez, F.F., Colman, S., Kauffman, L., Ruetsch, C., Anastassopoulos, K., & Maricich, Y.Real-World Reductions in Healthcare Resource Utilization over 6 Months in Patients with Substance Use Disorders Treated with a Prescription Digital TherapeuticLink to Publication
09/18/20222022PresentationPsych Congress 2022Hughes, T., Zeno, G., Wiggins, E., Yang, X., Liberman, J.N., Ruetsch, C.Relationship Between Patient Characteristics, Patterns of Treatment, and Medication Adherence among Individuals with Major Depressive Disorder: Implications of Delayed Initiation of PsychotherapyLink to Publication
10/14/20222022PresentationAMCP Nexus 2022Hughes, T., Zeno, G., Wiggins, E., Parab, P., Liberman, J.N., Ruetsch, CHealthcare Resource Utilization Costs among Individuals Treating MDD with Pharmacotherapy with and without Adjunctive PsychotherapyLink to Publication
10/14/20222022PresentationAMCP Nexus 2022Hughes, T., Zeno, G., Wiggins, E., Yang, X., Liberman, J.N., Ruetsch, CFactors Associated with Adding Adjunctive Psychotherapy for the Treatment of Major Depressive DisorderLink to Publication